PubRank

Claudio M Mastroianni

Author PubWeight™ 29.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection. Nat Med 2007 1.82
2 HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS. Curr HIV Res 2011 1.28
3 Pacemaker lead endocarditis due to multidrug-resistant Corynebacterium striatum detected with sonication of the device. J Clin Microbiol 2010 1.11
4 Influence of previous tuberculin skin test on serial IFN-γ release assays. Tuberculosis (Edinb) 2011 0.97
5 Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients. AIDS 2002 0.96
6 Severe and persistent depletion of circulating plasmacytoid dendritic cells in patients with 2009 pandemic H1N1 infection. PLoS One 2011 0.89
7 Discordant response to antiretroviral therapy: HIV isolation, genotypic mutations, T-cell proliferation and cytokine production. AIDS 2002 0.89
8 Plasmacytoid dendritic cells count in antiretroviral-treated patients is predictive of HIV load control independent of CD4+ T-cell count. Curr HIV Res 2008 0.88
9 Sonication of explanted cardiac implants improves microbial detection in cardiac device infections. J Clin Microbiol 2012 0.88
10 Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients. AIDS 2007 0.88
11 Interleukin-15 modulates interferon-gamma and beta-chemokine production in patients with HIV infection: implications for immune-based therapy. Cytokine 2004 0.86
12 Postpartum fever in the presence of a fibroid: Sphingomonas paucimobilis sepsis associated with pyomyoma. BMC Infect Dis 2013 0.86
13 In vitro downregulation of matrix metalloproteinase-9 in rat glial cells by CCR5 antagonist maraviroc: therapeutic implication for HIV brain infection. PLoS One 2011 0.84
14 Increased carotid intima media thickness is associated with depletion of circulating myeloid dendritic cells in HIV-infected patients on suppressive antiretroviral treatment. Atherosclerosis 2008 0.83
15 Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report. Medicine (Baltimore) 2016 0.82
16 The role of HIV-DNA testing in clinical practice. New Microbiol 2010 0.82
17 Interleukin-15 enhances the secretion of IFN-gamma and CC chemokines by natural killer cells from HIV viremic and aviremic patients. Immunol Lett 2005 0.82
18 Taming HIV-related inflammation with physical activity: a matter of timing. AIDS Res Hum Retroviruses 2014 0.81
19 Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis. Acta Trop 2006 0.80
20 Hepatitis B reactivation despite entecavir prophylaxis in a patient with chronic lymphocytic leukaemia receiving bendamustine. J Antimicrob Chemother 2011 0.79
21 Antiviral treatment including entecavir plus tenofovir disoproxil fumarate for HBV reactivation following a rituximab-based regimen. Antivir Ther 2010 0.79
22 The role of IL-15 in challenging Acquired Immunodeficiency Syndrome. Cytokine 2011 0.79
23 In vivo release of alpha-defensins in plasma, neutrophils and CD8 T-lymphocytes of patients with HIV infection. Curr HIV Res 2009 0.79
24 Simplified maintenance therapy with abacavir/lamivudine/zidovudine plus tenofovir after sustained HIV load suppression: four years of follow-up. HIV Clin Trials 2007 0.78
25 Recovery of interleukin-17 production from interleukin-15-stimulated CD4+ mononuclear cells in HIV-1-infected patients with sustained viral suppression. J Interferon Cytokine Res 2013 0.78
26 Dendritic cells in blood and urine samples from bladder cancer patients undergoing BCG immunotherapy. Arch Ital Urol Androl 2013 0.77
27 Extravirologic modulation of immune response by an NRTI-sparing antiretroviral regimen including darunavir and maraviroc. New Microbiol 2014 0.77
28 Switching from protease inhibitors to a single-class regimen of abacavir/lamivudine/zidovudine plus tenofovir in patients with HIV load suppression. AIDS 2005 0.77
29 Detecting latent tuberculosis in compromised patients. Curr Opin Infect Dis 2015 0.77
30 Development of Buffalo Hump in the course of antiretroviral therapy including raltegravir and unboosted atazanavir: a case report and review of the literature. J Med Case Rep 2011 0.77
31 Rapid identification of Bartonella henselae by real-time polymerase chain reaction in a patient with cat scratch disease. Diagn Microbiol Infect Dis 2005 0.77
32 QuantiFERON-TB Gold and selected region of difference 1 peptide-based assays for the detection of Mycobacterium tuberculosis infection in a cohort of patients enrolled with suspected tuberculosis. Diagn Microbiol Infect Dis 2008 0.77
33 Sonication technique improves microbiological diagnosis in patients treated with antibiotics before surgery for prosthetic joint infections. New Microbiol 2014 0.76
34 Case 11-2009: a man with fever, headache, rash, and vomiting. N Engl J Med 2009 0.75
35 Interferon-γ release assay in HIV-infected patients with active tuberculosis: impact of antituberculous drugs on host immune response. New Microbiol 2014 0.75
36 Bartonella henselae infection presenting with ocular and hepatosplenic manifestations in an immunocompetent child. Pediatr Infect Dis J 2012 0.75
37 Herpes virus reactivation after initiation of interferon-free antiviral agents in HIV-HCV-coinfected subjects: a new immune restoration disease? Antivir Ther 2016 0.75